tripelennamine has been researched along with Transfusion Reaction in 1 studies
Tripelennamine: A histamine H1 antagonist with low sedative action but frequent gastrointestinal irritation. It is used to treat ASTHMA; HAY FEVER; URTICARIA; and RHINITIS; and also in veterinary applications. Tripelennamine is administered by various routes, including topically.
Transfusion Reaction: Complications of BLOOD TRANSFUSION. Included adverse reactions are common allergic and febrile reactions; hemolytic (delayed and acute) reactions; and other non-hemolytic adverse reactions such as infections and adverse immune reactions related to immunocompatibility.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| STEPHEN, CR | 1 |
| MARTIN, RC | 1 |
| BOURGEOIS-GAVARDIN, M | 1 |
1 other study available for tripelennamine and Transfusion Reaction
| Article | Year |
|---|---|
Antihistaminic drugs in treatment of nonhemolytic transfusion reactions.
Topics: Anti-Allergic Agents; Blood Transfusion; Hypersensitivity; Transfusion Reaction; Tripelennamine | 1955 |